.@NPR spoke with Professor @CathyCluver, principal investigator of DiaMedica’s Phase 2 study, about the potential of DM199 for the treatment of #preeclampsia and her insights from the ongoing study. Read more: https://t.co/PLZv25V6wK
🥂To a fantastic Endpoints at #JPM26 edition, capped off with the best crew in all of biopharma
Thank you to all who joined us on stage, in the room, tuning in virtually.
Onto the rest of 2026, full speed ahead
Further, FDA had original PDUFA date for PAH/PAH-ILD of January 2024. Why would they set a date of January 2024 if they, at that point, believed exclusivity ran for another ~18 months? What made them change their mind? $LQDA
Our #ASH23 coverage kicks off in style with a dual expert interview on an emerging and potentially disruptive approach to tackling certain hematologic malignancies...
Who are they and what are doing?
Check 'em out! https://t.co/ITjmasusCF
I recently wrote a piece for Science Editor, offering an overview of how (and why) organizations might want to write news releases about scientific research. Thought it may be of interest to some #SciWri23 folks.
https://t.co/sLqtfxOqGH
CEO of #Flagshipfounded@TesseraTx Michael Severino speaks with @PharmaVoice on why he joined Flagship and his vision for Tessera.
Read more: https://t.co/DppEOD4OZ5
Tired of seen our faces on social media? 🫣
Well, get ready to see more! Introducing @LapsiHealth TV 📺 | Streaming the best content possible, tailored by us.
Our first two shows airing April 1st! 🤡
Do you like the sound of it? | https://t.co/c2UnHQeUqt
#digitalhealth #aprilfools #medicalinnovation #goals
Biotech startup @AltoNeuro announced today that one of its treatments, ALTO-100, showed promising signs for MDD. The company, founded by ex-Stanford professor
@AmitEtkin is focused on developing precision medicine for psychiatry based on biomarkers
https://t.co/3AEg285b4m
Headed home to Buffalo today with a lot of love on my heart. 🫶🏾
Watching the world come together around me on Sunday was truly an amazing feeling.
The same love you all have shown me is the same love that I plan to put back into the world n more.
Bigger than football! 🫶🏾
Our CEO, Matt Middleman, MD, was featured by @MMMnews to share six campaigns that shed light on under-recognized populations, such as those impacted by health disparities or societal norms, touching on #MentalHealth, #TNBC, #BeautyBias, & more. Read here: https://t.co/s45R4X1p2c
NEW: We started this project asking a big question:
Who are the next Bruce Booth's, Bob Nelsen's, and Noubar Afeyan's of biotech VC?
The result: 16 pioneering VCs to watch who are reshaping the biotech's future with new investing ideas: https://t.co/LKv2pXfvSK